Immunophenotyping enables increasingly precise characterization of Multiple sclerosis immuno-pathogenesis. While not yet routine, these tools show promise for improving differential diagnosis, individualizing therapy initiation and monitoring. Ongoing research and standardization are paving the way towards precision immunology-approaches in clinical practice.
Möllenkamp et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: